This HTML5 document contains 134 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37310514
rdf:type
wikibase:Item
schema:description
videnskabelig artikel bilimsel makale наукова стаття, опублікована в лютому 2009 article científic مقالة علمية نشرت في فبراير 2009 wissenschaftlicher Artikel scientific article published on February 2009 artigo científico vetenskaplig artikel vědecký článek научни чланак article scientifique wetenschappelijk artikel artículu científicu espublizáu en 2009 vedecký článok articolo scientifico
p:P577
wds:Q37310514-E45BF95B-EAB5-4030-85E5-B18273734623
wdt:P577
2009-02-01T00:00:00Z
p:P2860
wds:Q37310514-9649156C-610D-4FE5-A051-6490FBC56D59 wds:Q37310514-9CA8865C-C680-4443-931E-51B5411B5D2F wds:Q37310514-E514CBB6-D92B-4D60-9201-027D3921735B wds:Q37310514-D1495E90-2D7C-470C-B475-0BBB029AEA71 wds:Q37310514-D5AC7D29-3924-40E5-86A5-874935AE8C68 wds:Q37310514-F7E77E35-4AFB-4886-AA75-DAB1A76F42AF wds:Q37310514-F871EED0-66F2-4C0A-9BD8-01233D7B5ABB wds:Q37310514-E77ED291-AD5F-4768-B432-98431E750BD9 wds:Q37310514-F10A6750-A664-4580-BB60-FBC1BAD1CAF2 wds:Q37310514-F303DBD9-E077-45DF-A21C-F58135C45E54 wds:Q37310514-F8EC1F56-8FBD-47FE-95EC-C6E4722762AC wds:Q37310514-FAA6ECD7-D23A-404A-A499-9C13A4DA8442 wds:Q37310514-FBF6807E-3160-4F79-92BD-930F4CF41A4C wds:Q37310514-1B8AAF9B-4308-44DA-8ACD-03871767069B wds:Q37310514-0B873A66-15EB-4C4C-9B3A-7103C7A258AF wds:Q37310514-4C94248B-8EA8-440E-8945-EF5228ABD80C wds:Q37310514-2747893D-80CD-433F-B165-DC7F5484D22A wds:Q37310514-3C1D5080-1845-4E6F-A653-3E766BFBA6D0 wds:Q37310514-414F9946-58D3-4321-83EA-7187667C46EC wds:Q37310514-5DBE6174-7140-4B12-91C1-BD6CA14A46F4 wds:Q37310514-9D27CE4B-6510-4043-B783-4BB4D5653013
wdt:P2860
wd:Q47759255 wd:Q40632321 wd:Q33773306 wd:Q40459857 wd:Q44885630 wd:Q41610810 wd:Q31983905 wd:Q52645482 wd:Q68728071 wd:Q77378845 wd:Q34565132 wd:Q40381373 wd:Q35036892 wd:Q35750990 wd:Q35750976 wd:Q35067047 wd:Q34566901 wd:Q52583941 wd:Q53652574 wd:Q73825073 wd:Q28248195
p:P2093
wds:Q37310514-F775360C-86E7-4E65-99B0-57FF5079D4E3 wds:Q37310514-9ED31641-A67D-4007-8B45-41ACC9A5DD01 wds:Q37310514-E61AB0CA-1310-4EB3-B9FE-490B103CDD3E wds:Q37310514-3AB55C7B-5966-43AA-9556-0E6F72C9C8BE wds:Q37310514-4209B6A3-110D-4921-8C95-5B33B277EFA4 wds:Q37310514-47651330-FA89-4B3C-9063-565B1A456107 wds:Q37310514-6A6959D3-EE7E-469A-8934-A92E086781C8 wds:Q37310514-70820744-0DDC-4FB4-88E1-3C9CB35B0059 wds:Q37310514-93464407-25E9-470E-B95B-2CEDCCEC63E3 wds:Q37310514-71950CB1-4323-4A95-89F6-1B4D3C213AF9 wds:Q37310514-178F2161-D66F-491B-95F0-F1F4F2E9C950 wds:Q37310514-19666CF0-CD58-446E-A07F-D30F4AEA5CD2
wdt:P2093
Timothy C Griffin Mitchell Cairo Bruce Shiramizu Children's Oncology Group Thomas G Gross Howard Weinstein Margaret Barnich Robert Hutchison Deborah Woods Joseph Wiley Sheila Weitzman Myron Chang
rdfs:label
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
skos:prefLabel
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
schema:name
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
p:P1476
wds:Q37310514-D3CBCE96-1108-4BBC-9EA9-2C7FDD4AF023
wdt:P1476
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
p:P304
wds:Q37310514-0804B433-EFF3-43A7-9ABA-C803204D5AFF
wdt:P304
177-181
p:P31
wds:Q37310514-C501D164-B386-4ECD-9270-CD97D4D8F785
wdt:P31
wd:Q13442814
p:P921
wds:Q37310514-D1F08016-7378-46E3-875E-5230AB1CE3E4 wds:Q37310514-DBAFBBD9-5960-4183-9BED-8E3C38BC53EA wds:Q37310514-998F085F-B176-4679-A0E9-4914B959DF65 wds:Q37310514-FD6CE2C0-FF55-41C2-9954-CD3C3D86D866 wds:Q37310514-EC8ACB60-C5E7-48D5-9F68-B7A8F75035D8 wds:Q37310514-143F080D-201A-4F56-B668-28C6BD32ED53 wds:Q37310514-1DDAE80D-9B3F-4F26-9672-63D31FE3DEE1 wds:Q37310514-5FACD13C-D700-40CE-A49A-CF16E6C8B164 wds:Q37310514-7463C273-966D-4A1F-ADB5-7D69086709EE
wdt:P921
wd:Q1138590 wd:Q418817 wd:Q29496 wd:Q102293395 wd:Q418560 wd:Q415588 wd:Q974135 wd:Q412323 wd:Q18553852
p:P698
wds:Q37310514-19377C64-EE84-4EA8-B04D-5B37CF669E0E
wdtn:P698
n10:18816698
wdt:P698
18816698
p:P1433
wds:Q37310514-5C647D89-6A99-42FD-99A6-396C403B6E15
wdt:P1433
wd:Q15754342
p:P433
wds:Q37310514-B3479C73-660C-4B33-99DC-E20ACAE9AB53
p:P478
wds:Q37310514-7D760137-EE2D-4C25-8B47-018C02F554B2
wdt:P433
2
wdt:P478
52
p:P356
wds:Q37310514-F352CF15-486E-4CAD-B1EA-2F59F6720D2B
wdtn:P356
n11:PBC.21753
wdt:P356
10.1002/PBC.21753
p:P5875
wds:Q37310514-9AEDA773-5320-49C6-AC86-673BA9494D64
wdt:P5875
23281242
p:P932
wds:Q37310514-1A2C014F-DB4E-4A57-8EE9-22B4E92878A2
wdt:P932
2728935